LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing […]
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune […]
Nano Dimension Announces Preliminary All Cash Proposal to Acquire Stratasys for $16.50 per share
Waltham, Mass., Dec. 23, 2023 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, or “Nano” or the “Company”), […]
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing […]
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
BOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, today announced that Institutional Shareholder […]
Super League Announces Private Placement Financing of $8.354 Million and Enters into Accounts Receivable Facility to Further Fund Growth Initiatives
SANTA MONICA, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE), a global leader in providing immersive experiences […]
Millicom (Tigo) share repurchase activity
Millicom (Tigo) share repurchase activity Luxembourg, December 22, 2023 – Pursuant to the share repurchase program announced on December 15, […]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, […]
FLJ Group Limited Announces Appointment of Directors
SHANGHAI, China, Dec. 22, 2023 (GLOBE NEWSWIRE) — FLJ Group Limited (NASDAQ: FLJ) (the “Company”), today announced that (i) Ms. […]
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Dec. 22, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for […]
